Cargando…
The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
In infants, especially with novel previously undescribed mutations of the K(ATP) channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if the expected response...
Autores principales: | O'Connell, Susan M, Proks, Peter, Kramer, Holger, Mattis, Katia K, Sachse, Gregor, Joyce, Caroline, Houghton, Jayne A L, Ellard, Sian, Hattersley, Andrew T, Ashcroft, Frances M, O'Riordan, Stephen M P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614663/ https://www.ncbi.nlm.nih.gov/pubmed/26509030 http://dx.doi.org/10.1002/ccr3.370 |
Ejemplares similares
-
Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A K(ATP) channels: A mechanistic study
por: Proks, Peter, et al.
Publicado: (2014) -
Mutations within the P-Loop of Kir6.2 Modulate the Intraburst Kinetics of the Atp-Sensitive Potassium Channel
por: Proks, Peter, et al.
Publicado: (2001) -
Phenotype of a transient neonatal diabetes point mutation (SUR1-R1183W) in mice
por: Sachse, Gregor, et al.
Publicado: (2021) -
Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism
por: Shimomura, Kenju, et al.
Publicado: (2009) -
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications
por: Tammaro, P., et al.
Publicado: (2008)